Our RT-qPCR and western blot analysis corroborate with ITGB6 expression in primary tumor samples and its normal counterparts through UALCAN analysis, demonstrating a significant overexpression of this protein in tumor samples compared to controls. The gene discussed is ITGB6; the disease is neoplasm.